Login to Your Account

In the clinic

Monday, July 14, 2014
Genticel SA, of Toulouse, France, said the phase II RHEIA-VAC (Research on HPV Eradication In Adults by VACcination) study reached the halfway mark in patient enrollment, with all 39 sites across seven countries in Europe fully operational.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription